Role of transforming growth factor β1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome

American Journal of Hematology

Volumn 66, Issue 1, 2001, Pages 12-22

  Mauro, Michael ^a   Kim, Jiyun ^a   Costello, Christin ^a   Laurence, Jeffrey ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell death, programmed; Endothelial cell; Hemolytic uremic syndrome; Human immunodeficiency virus; Purpura, thrombotic thrombocytopenic; Thrombospondin; Ticlopidine; Transforming growth factor

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYTOKINE; FIBRONECTIN; SCLEROPROTEIN; THROMBOSPONDIN; TICLOPIDINE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL LINEAGE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROVASCULATURE; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

APOPTOSIS; CELL CYCLE; CELL LINEAGE; CELLS, CULTURED; CORONARY VESSELS; CULTURE MEDIA, SERUM-FREE; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HEMOLYTIC-UREMIC SYNDROME; HIV INFECTIONS; HUMANS; LIVER; ORGAN SPECIFICITY; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RNA, MESSENGER; SKIN; TETRADECANOYLPHORBOL ACETATE; THROMBOSPONDINS; TICLOPIDINE; TONSIL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035176926     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200101)66:1<12::AID-AJH1001>3.0.CO;2-I     Document Type: Article

References (39)

1. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells
2. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells
3. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome
4. Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies
5. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen
6. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura
7. Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature
8. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
9. Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome in HIV-infected patients
10. Thrombotic thrombocytopenic purpura associated with ticlopidine
11. The extracellular matrix as a cell survival factor
12. Expression of laminin 5, fibronectin, and epithelium-associated integrins in recurrent aphthous ulcers
13. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions
14. Effects of ticlopidine and dexamethasone on fibronectin and factor VIII-related antigen synthesis by cultured endothelial cells
15. Angiogenesis inhibitor SR 25989 upregulates thrombospondin-1 expression in human vascular endothelial cells and foreskin fibroblasts
16. Association of circulating receptor FcγRIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β
17. Increased serum levels of transforming growth factor β-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): Its implications on bone marrow hematopoiesis
18. Defective angiogenesis in mice lacking endoglin
19. Transforming growth factor-β in tissue fibrosis
20. Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva
21. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism
22. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
23. 1 phase of the cell cycle
24. Vascular-bed-specific hemostasis and hypercoagulable states
25. Activated platelet aggregates in thrombotic thrombocytopenic purpura: Decrease with plasma infusions and normalization in remission
26. Platelet-derived growth factors as possible mediators of vascular proliferation in the sporadic hemolytic uremic syndrome
27. Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells
28. Dual pathways triggered by Fas-FasL interaction in endothelial cells: Induction of apoptosis via CPP32-like caspases and inhibition of apoptosis requiring de novo protein synthesis
29. Overexpression of transforming growth factor β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia
30. Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2
31. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors
32. Endothelial proliferation in tumors and normal tissues: Continuous labeling studies
33. Double identity for proteins of the Bcl-2 family
34. Cell-cycle control and renal disease
35. The lonely failing heart: A case for ECM genes
36. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration
37. Thrombospondin-1 is a major activator of TGF-β1 in vivo
38. Ticlopidine induced colitis: A histopathological study including apoptosis
39. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura